Design and analysis of post-marketing research

被引:3
|
作者
Zhou, Xiao-Hua [1 ,2 ,3 ]
Wei, Yang [4 ]
机构
[1] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA
[2] Renmin Univ China, Sch Stat, Beijing 100872, Peoples R China
[3] VA Seattle Med Ctr, Biostat Unit, Seattle, WA USA
[4] China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing 100700, Peoples R China
关键词
traditional Chinese medicine post-marketing research; safety surveillance; pharmacovigilance methods; propensity score; ADJUSTMENT;
D O I
10.1007/s11655-013-1501-z
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
A post-marketing study is an integral part of research that helps to ensure a favorable risk-benefit profile for approved drugs used in the market. Because most of post-marketing studies use observational designs, which are liable to confounding, estimation of the causal effect of a drug versus a comparative one is very challenging. This article focuses on methodological issues of importance in designing and analyzing studies to evaluate the safety of marketed drugs, especially marketed traditional Chinese medicine (TCM) products. Advantages and limitations of the current designs and analytic methods for postmarketing studies are discussed, and recommendations are given for improving the validity of postmarketing studies in TCM products.
引用
收藏
页码:488 / 493
页数:6
相关论文
共 50 条
  • [21] Post-marketing surveillance of sertindole
    Toumi, M
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2002, 6 : S33 - S35
  • [22] POST-MARKETING DRUG SURVEILLANCE
    WALDEN, RJ
    PRICHARD, BNC
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (03) : 191 - 192
  • [23] Post-marketing strategies for medicines
    Breckenridge, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (01) : 24 - 25
  • [24] POST-MARKETING SURVEILLANCE OF DRUGS
    HARCUS, AW
    WARD, AE
    SMITH, DW
    BRITISH MEDICAL JOURNAL, 1979, 2 (6194): : 867 - 867
  • [25] POST-MARKETING SURVEILLACE OF THE RETINOIDS
    Diane ChenHead Drug Safety F HoffmannLa Roche CoPostfach CH Basel
    中国临床药理学杂志, 1988, (04) : 222 - 227
  • [26] A PRESCRIPTION FOR POST-MARKETING SURVEILLANCE
    ROUTMAN, KD
    DRUG & COSMETIC INDUSTRY, 1980, 126 (06): : 60 - 64
  • [27] Post-marketing studies of pharmaceutical opioid abuse-deterrent formulations: a framework for research design and reporting
    Peacock, Amy
    Larance, Briony
    Bruno, Raimondo
    Pearson, Sallie-Anne
    Buckley, Nicholas A.
    Farrell, Michael
    Degenhardt, Louisa
    ADDICTION, 2019, 114 (03) : 389 - 399
  • [28] FDA post-marketing safety decisions
    Klein, Donald F.
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (08) : 1305 - 1306
  • [29] POST-MARKETING SURVEILLANCE OF NEW MEDICINES
    SMITHELLS, RW
    BRITISH MEDICAL JOURNAL, 1977, 2 (6096): : 1218 - 1218
  • [30] POST-MARKETING SURVEILLANCE BY DRUG MANUFACTURERS
    不详
    LANCET, 1988, 2 (8617): : 977 - 977